D

"Basic research only" has become a battle cry for those who would like to slash funding for federal scientific research and development programs. But following that war path would be a serious misstep if the goal is-as it should be-to get an effective return on the federal scientific investment. In fact, federal support for the development part of R&D is already woefully insufficient to ensure that the benefits of research advances are fully realized. Basic research is just the first leg

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

"Basic research only" has become a battle cry for those who would like to slash funding for federal scientific research and development programs. But following that war path would be a serious misstep if the goal is-as it should be-to get an effective return on the federal scientific investment. In fact, federal support for the development part of R&D is already woefully insufficient to ensure that the benefits of research advances are fully realized.

Basic research is just the first leg on the journey to the marketplace for new technologies. For many projects, that basic research is federally funded and motivated by societal goals such as promoting health, environmental quality, and safety. The final leg of inserting the technology into product manufacturing processes is privately funded and motivated by customer demand and profit motives. In between, however, is an inadequate mix of public and private funding. Those middle stages of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Marczewski

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo